FDA Approves Emergency Authorization For COVID-19 Saliva Test

FDA Approves Emergency Authorization For COVID-19 Saliva Test

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

Yale University developed a new coronavirus test called Saliva Direct, which is less invasive and cheaper than nasal swabs. Although not yet peer-reviewed, it shows similar accuracy to nasal tests. The FDA has granted emergency authorization, and the NBA has used it for daily testing. Saliva Direct could be a significant advancement in public health testing, costing around $10 per sample.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main advantage of the Saliva Direct test compared to nasal swab tests?

It is more expensive.

It is less invasive.

It takes longer to get results.

It requires more equipment.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What has the FDA said about saliva tests in general?

They are not suitable for emergency use.

They have shown varied results.

They are always more accurate than nasal swabs.

They have shown consistent results.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which organization partnered with Yale for testing as the league restarted its season?

NHL

NBA

MLB

NFL

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the expected cost per sample for the Saliva Direct test?

$10

$5

$50

$20

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What potential does the Saliva Direct test have according to Yale?

To replace all other tests

To be used on a larger scale to protect public health

To be used only in sports leagues

To be more expensive than other tests